Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Kliovance

Kliovance is a medicine containing the active ingredient(s) estradiol + norethisterone acetate. On this page you will find out more about Kliovance, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: estradiol + norethisterone acetate

Information for medicine and pack size:
Kliovance film-coated tablet, 28

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Short term treatment of menopausal symptoms related to oestrogen deficiency in women more than one year after menopause (see DOSAGE AND ADMINISTRATION and CLINICAL TRIALS). For the prevention of postmenopausal bone mineral density loss. When prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of osteoporosis and future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of osteoporosis. Life style modifications and the risk benefit profiles of Kliovance should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing. See PRECAUTIONS and DOSAGE AND ADMINISTRATION.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance White, round, film-coated tablets 6mm in diameter. Tablets are engraved with NOVO 288 on one side and the Novo Nordisk logo on the other.

Images are the copyright of the Pharmacy Guild of Australia

Dosage Form Tablet, film coated
Route of administration Oral
Medicine schedule
28 tablets: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Dial Dispenser Pack
Storage temperature Store below 25 degrees Celsius
Storage conditions Store in a Dry Place,Protect from Light,Do not Refrigerate
Life time 2 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 4 results

Kliovance | myVMC

Kliovance is a hormone replacement therapy used to treat menopausal symptoms cause by oestrogen deficiency and prevent osteoporosis.

Read more on myVMC – Virtual Medical Centre website

Kliovance Tablets - myDr.com.au

Kliovance Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Menorest | myVMC

Menorest is a hormone replacement therapy containing oestrodial. It is used to treat symptoms of menopause and prevent menopausal osteoporosis.

Read more on myVMC – Virtual Medical Centre website

Hormone replacement therapy - myDr.com.au

Hormone replacement therapy (HRT) is not a quick fix to the challenge of menopause, but it can be a useful tool in the overall management of menopause.

Read more on myDr website

Check your symptoms Find a health service

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback